TickerFacts.

Niagen Bioscience, Inc. (NAGE): Cost of Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-01-02 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$46.23M
Year ended 2025-12-31
$46.16M
Trailing 12 months to 2026-06-30
+16.5%
3-year compound annual growth
+14.0%
5-year compound annual growth
+16.1%
10-year compound annual growth
2011-01-01: $4.62M2011-12-31: $5.64M2012-12-29: $9.34M2013-12-28: $7.03M2015-01-03: $9.99M2016-01-02: $10.35M2016-12-31: $11.27M2017-12-30: $10.72M2018-12-31: $15.50M2019-12-31: $20.52M2020-12-31: $23.98M2021-12-31: $25.96M2022-12-31: $29.25M2023-12-31: $32.79M2024-12-31: $38.01M2025-12-31: $46.23M$46.23M
2011-01-01 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$46.23M+21.6%2026-03-04, From 2025-01-01
2024-12-31$38.01M+15.9%2026-03-04, From 2024-01-01
2023-12-31$32.79M+12.1%2025-03-04, From 2023-01-01
2022-12-31$29.25M+12.7%2024-03-06, From 2022-01-01
2021-12-31$25.96M+8.2%2023-03-08, From 2021-01-01
2020-12-31$23.98M+16.9%2022-03-14, From 2020-01-01
2019-12-31$20.52M+32.4%2021-03-12, From 2019-01-01
2018-12-31$15.50M+44.6%2020-03-10, From 2017-12-31
2017-12-30$10.72M-4.9%2019-03-07, From 2017-01-01
2016-12-31$11.27M+8.9%2018-03-15, From 2016-01-03
2016-01-02, Fiscal 2015$10.35Mn/c2018-03-15, From 2015-01-04
2015-01-03, Fiscal 2014$9.99M+42.1%2017-03-16, From 2013-12-29
2013-12-28$7.03M-24.7%2016-03-17, From 2012-12-30
2012-12-29$9.34M+65.5%2014-03-27, From 2012-01-01
2011-12-31$5.64M+22.1%2013-03-29, From 2011-01-02
2011-01-01, Fiscal 2010$4.62Mn/a2012-03-15, From 2010-01-03

Cost of Revenue at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Niagen Bioscience, Inc. (NAGE)2025-12-31$46.23M+21.6%
Natural Alternatives International Inc (NAII)2026-06-30$133.52M+10.7%
Mannatech Inc (MTEX)2025-12-31$27.08M+2.5%
Marimed Inc. (MRMD)2025-12-31$101.94M+7.2%
Glass House Brands Inc. (GLAS)2025-12-31$105.02M+1.5%
Fitlife Brands, Inc. (FTLF)2025-12-31$50.01M+37.4%
Jushi Holdings Inc. (JUSH)2025-12-31$148.93M+7.0%
Leef Brands Inc. (LEEEF)2025-12-31$24.30M+16.8%
Ascend Wellness Holdings, Inc. (AAWH)2025-12-31$330.90M-12.3%

Compare NAGE, NAII, MTEX, MRMD side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗